Company news: Cann Group; AusCann; Emyria; Avecho by Steve Jones June 13, 2024June 13, 2024 Cann Group chairman Julian Chick has acquired 250,000 shares in the business, with new chief executive […]
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Cann Compounding; Ecofibre; Ora Pharm; Althea; Melodiol Global Health; Wellnex Life; Emyria by Martin Lane and Steve Jones April 24, 2024April 24, 2024
Emyria inks deal to study MDMA-assisted therapy for first responders by Martin Lane April 3, 2024July 16, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024July 16, 2024
Emyria S3 CBD trial ‘on hold’ as firm stresses need to focus on revenue by Steve Jones February 7, 2024February 7, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024July 11, 2024